-
Prenatal Exposure to Antiseizure Medication and Risk of Adverse Obstetrical Outcomes: A Population-Based Study
Mar 10, 2025, 14:00 PM -
Are Commercial Insurance Premiums Associated With the 340B Drug Pricing Program?
Mar 10, 2025, 14:00 PM -
Association Between Vaginal Progesterone Use and Risk of Preterm Birth Among High-Risk Pregnancies: A Real-World Evidence Study
Mar 10, 2025, 14:00 PM -
The Association Between COVID-19 Vaccination History and the Incidence of COVID-19 and Healthcare Resource Use in Rural Residents in Japan
Mar 10, 2025, 14:00 PM -
Adherence to Anti-Tubercular Medications in the United States: Insights from MarketScan Data (2016-2021)
Mar 10, 2025, 14:00 PM -
Retrospective Analysis of Cannabis Hyperemesis Syndrome (CHS) Using US Electronic Medical Records: Demographics and Clinical Characteristics
Mar 10, 2025, 14:00 PM -
Comparative Risk of Major Adverse Cardiovascular Events among Patients who Initiate Treatment with Acute Migraine Agents
Mar 10, 2025, 14:00 PM -
Characterization of Economic Burden in Individuals With Narcolepsy or Idiopathic Hypersomnia at Higher Risk of Sodium-Associated Negative Clinical Outcomes in the United States
Mar 10, 2025, 14:00 PM -
Epidemiological and Economic Analysis of Hospitalizations for Cellulitis and Erysipelas From the Perspective of a Brazilian Health Insurance Company
Mar 10, 2025, 14:00 PM -
Patient, Caregiver, and Physician Perspectives on the Burden of Disease Chronic Refractory Gout and Its Treatment: Concept Elicitation
Mar 10, 2025, 14:00 PM -
Real-World Utilization and Predictors of Neurohormonal Inhibitors Use in Young and Middle-Aged Breast Cancer Patients, Initiating Anthracycline-Based Treatments
Mar 10, 2025, 14:00 PM -
Administrative Frequency of Vitiligo and Clinical Characteristics in a Colombian HMO: A Real World Data Characterization From 2015 to 2023
Mar 10, 2025, 14:00 PM -
Content Validation of the Patient Attainment Scale-Essential Tremor (PAS-ET): A Novel Patient-Reported Outcome Measure Assessing Patient-Level Perceptions of the Importance, Current Function and Definitions of Meaningful Improvement in Tremor-Related...
Mar 10, 2025, 14:00 PM -
Trends in the Global Drug Development Pipeline 2024
Mar 10, 2025, 14:00 PM -
Advancing Real World Evidence: Comparative Insights into Global Practices and China's Strategic Progress
Mar 10, 2025, 14:00 PM -
Measurement of Short-Term Functional Outcome Using Modified Rankin Scale in Patients With Acute Ischaemic Stroke
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Single-Inhaler Extrafine Beclometasone Dipropionate/formoterol fumarate/glycopyrronium (Trimbow®) in Adult Patients with Uncontrolled Asthma in Mexico
Mar 10, 2025, 14:00 PM -
The Prevalence of Fractional-Polynomial Network Meta-analyses (fpNMAs) in Supporting Reimbursement Recommendations by Canada's Drug Agency (CDA-AMC)
Mar 10, 2025, 14:00 PM -
Patient Optimism and the Trade-Off Between Kidney Quality and Waiting Time
Mar 10, 2025, 14:00 PM -
Determination of Medication Regimen Complexity Trends in Older Adult Patients With Insomnia: A Triangulation of Findings From Artificial Neural Network and Logistic Regression Analyses
Mar 10, 2025, 14:00 PM